MADE as of the 27th day of May, 2008Arrangement Agreement • December 23rd, 2008 • GrowthWorks Capital Ltd. • In vitro & in vivo diagnostic substances • British Columbia
Contract Type FiledDecember 23rd, 2008 Company Industry JurisdictionTHIS AGREEMENT WITNESSETH THAT in consideration of the respective covenants and agreements herein contained and for other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged by each party), the parties hereby covenant and agree as follows:
AGREEMENTAgreement • September 2nd, 2008 • GrowthWorks Capital Ltd. • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 2nd, 2008 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Oncogenex Pharmaceuticals, Inc.
ESCROW AGREEMENTEscrow Agreement • September 2nd, 2008 • GrowthWorks Capital Ltd. • In vitro & in vivo diagnostic substances • British Columbia
Contract Type FiledSeptember 2nd, 2008 Company Industry JurisdictionSONUS PHARMACEUTICALS, INC., to be renamed OncoGenex Pharmaceuticals, Inc., a corporation existing under the laws of the State of Delaware